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INTRODUCTION
Hyponatremia  is  the  most  common  electrolyte  disorder  among 
hospitalized  patients  and  has  been  associated  with  increased  mortality. 
Hyponatremia is defined as a serum sodium concentration (Na+) less than 135 
mEq/L.
Serum  sodium  levels  and  serum  osmolality  are  normally  maintained 
under precise control by homeostatic mechanisms involving thirst, anti-diuretic 
hormone and the renal handling of filtered sodium.  Hyponatremia occurs in a 
broad spectrum of patients who are asymptomatic or critically ill.
Patients  in  whom the  serum sodium concentration  is  greater  than 130 
mEq/L are usually asymptomatic, whereas those in whom these values are lower 
may have symptoms.   Clinical  symptoms vary from individual to individual. 
Majority of patients with hyponatremia are asymptomatic.  Most patients with 
hyponatremia have non-specific symptoms or symptoms due to an underlying 
disease or disorder.  The clinical manifestations of hyponatremia are produced 
by brain swelling and are primarily a function of the rate of fall of serum sodium 
concentration  and  not  the  absolute  level.   Symptoms  occurring  early  in 
hyponatremia is usually anorexia, nausea, vomiting.  Some patients may have 
headache and irritability.  As serum sodium levels falls further patients develop 
neuropsychiatry symptoms.                              
These symptoms range from restlessness, altered consciousness, lethargy, 
seizures  to  coma.   As  the  symptomatology  vary  markedly,  the  diagnosis  of 
hyponatremia  is  difficult  to  establish.   Prompt  recognition  and  optimal 
management  of  hyponatremia  in  hospitalized  patients  may reduce in-hospital 
mortality and symptom severity, allow for less intensive hospital care, decrease 
the duration of hospitalization and associated costs and improve the treatment of 
underlying co morbid conditions and patients’ quality of life.  So the treating 
clinician should have a high index of suspicion to diagnose hyponatremia.
There are serious neurological sequelae associated with hyponatremia and 
its management.  The possible causes of hyponatremia should always be sought 
in every case.  The presence of symptoms and duration of hyponatremia guide 
the  treatment  strategy.   Thorough  evaluation  for  hyponatremia  mandates 
accurate  history  taking  and  clinical  examination  along  with  various 
investigations.
        AIMS AND OBJECTIVES OF THE STUDY
 To study the incidence of hyponatremia in hospitalized adult patients in 
medical wards.
 To determine the etiology of clinically significant hyponatremia in 100 
patients in medical wards.
 To determine the clinical presentation of hyponatremia in these patients.
 To study whether the primary disease is a cause for hyponatremia and 
whether other features cause hyponatremia also.
 To study whether hyponatremia adds to morbidity and mortality.
 To study the various diseases associated with hyponatremia.      
REVIEW OF LITERATURE
INCIDENCE
Hyponatremia is common in both inpatients and outpatients1.It is the most 
common  electrolyte  disorder  among  hospitalized  patients2,3,4, and  has  been 
associated with increased mortality5 ranging from 5% to  50%, depending on 
severity  and acuity of  onset6.   Its  prevalence among non-hospitalized elderly 
patients has been estimated to be between 7 – 11.4%, increasing to 11 – 22.5% 
among hospitalized  patients7.   The  precise  incidence  of  hyponatremia  varies 
depending on the  conditions  underlying  it  and the  criteria  used  to  define  it. 
When  defined  as  a  serum  sodium  concentration  of  less  than  135  mEq/L, 
hyponatremia has  been reported in 15% to 22% of hospitalized patients.   In 
studies defining it as a concentration of 130 mEq/L or less, hyponatremia has 
been  described  in  hospitalized  patients  at  incidences  of  1%  to  4%8,9 and  a 
prevalence of 2.9%10.  A study done by Kende M et al in over 30,000 patients 
over  two  years  observed  that  hyponatremia  was  higher  among  medical  and 
pediatric patients11.  Various studies have indicated that elderly patients showed 
a higher predisposition to develop hyponatremia12,13.  Natkunam et al observed 
that  majority  of  patients  developed hyponatremia during their  hospital  stay14. 
Various  studies  have  emphasized  the  susceptibilities  of  hospitalized  elderly 
patients to hyponatremia15,16.  
Studies have shown that elderly patients are more prone to hyponatremia 
as  a  result  of  conditions  such  as  cardiac,  renal  and  hepatic  failure15,17, 
physiological changes such as a decrease in glomerular filtration rate,18,19 altered 
water metabolism20 and polypharmacy21.  Hyponatremia in elderly in-patients is 
common during in-hospital stay is strongly associated with increased length of 
stay and loss of independence22.  
PHYSIOLOGY OF SODIUM AND FLUID BALANCE
Sodium  is  the  predominant  cation  in  extra-cellular  fluids16.   The 
molecular weight of sodium is 23 and valency is 1+.  Osmolality is the total 
number of solute particles dissolved in a given volume of solvent.  It is measured 
by number of milli-osmoles of solutes dissolved in one Kg per liter of water.  
The dissociability of particular solute determines its contribution to osmolality.
Plasma osmolality can be calculated using the following formula:
Mosm/kg = 2(Na+ mmol/L) + glucose (mg/dl)/18 + urea (mg/dl)/623
Physiology of Osmosis
Cell membranes throughout the body are freely permeable to water but 
are impermeable to various solutes.  Osmotic fluid movement occurs when such 
a  water  permeable  membrane  separates  two  compartments  with  different 
concentrations of impermeable solutes.  The difference between the osmolality 
on the two sides is called the osmotic gradient.  Osmotic gradient determines the 
amount of fluid that will passively move to equalize the osmolality on the two 
sides. 
Most body fluids are iso-osmotic with plasma or cell interior.  In a few 
places, high osmotic gradients are maintained as seen in renal medulla.  This is 
made possible by specialized water impermeable membranes.  
COMPOSITION OF VARIOUS FLUID COMPARTMENTS
The  total  body  water  is  about  54  percent  of  body  weight  in  normal 
individual.   15  –  20  percent  may  comprise  the  extra-cellular  fluid,  which 
includes plasma and interstitial fluid24.
Table 1
VOLUMES OF BODY FLUID COMPARTMENTS
TOTAL BODY WATER 40L
INTRA-CELLULAR VOLUME 24L 60%
PLASMA 3.2L 8%
INTERSTITIAL FLUID 11.2L 28%
TRANSCELLULAR FLUID 1.6L 4%
A NORMAL MAN WEIGHING 70 KG USED AS MODEL
The total body water is measured by various dilution techniques using 
isotopes like deuterium or tritium.  
Table 2
VOLUME AND COMPOSITION OF BODY FLUIDS
Measure Intra-cellular Extra-cellular
Plasma Interstitial
Water ml/kg 400 (330 – 450) 50 (45 – 35) 150 (120 – 220)
CATIONS m mol/L
Na 3 140 135(-145) 135 (130 – 140)
K 140(120 – 160) 4.5 (3.5 – 5.0) 4.5(3.5 – 4.5)
Ca 2(1.5 – 2.5) 2.5 (2 – 3) 1.5 (1 – 2)
Mg 15(12 – 17) 2.0 1.5
ANIONS m mol/L
Cl 6 (4 – 9) 103 (95 – 110) 108 (100 – 115)
HCO3 8 (6 – 10) 26 (22 – 30) 27 (22 – 30)
PHOSPHATES 2 2
SULPHATES 2 2
ORGANIC ACIDS 16 3 3
ORGANIC 
PHOSPHATES
75
OTHER m mol/L
UREA 4 4
GLUCOSE 4 5 (4 – 6) 5 (4 – 6)
OSMOLALITY 
(m Osm/L)
287 (280 – 295) 287 (280 – 295) 287 (280 – 295)
As  evident  from  table-2,  the  body  fluids  are  in  osmotic  equilibrium. 
Various control mechanisms acting through osmo-receptors function to maintain 
the osmolalaity in a very narrow range. The volume of extra-cellular fluid is 
maintained  by  reflex  mechanisms  through  volume  receptors  to  maintain 
circulating volume.
REGULATION OF SODIUM AND WATER BALANCE
           Sodium is the dominant cation in extra-cellular fluid and total body  
sodium  balance  is  primary  determinant  of  extra-cellular  fluid  volume. 
Hyponatremia represents a state where there is excess of water with respect to 
sodium.  Both water and sodium are in a state of exchange with the environment 
as show in the table-324.
Table 3
SODIUM AND WATER BALANCE IN A NORMAL INDIVIDUAL
Source Water intake Source Water output
INGESTED 
CONTENT  IN 
FOOD 
OXIDATION
Obligatory Elective 
URINE
Obligataory Elective
400 1000 500 1000
850
350
SKIN
STOOL
RESPIRATIOAN
500
200
400
TOTAL 1600 1000 1600 1000
 
DIETARY
INCIDENTAL
Sodium Intake
(m mol / Kg / day)
1.0
1.9
URINE
FAECES
INSENSIBLE
Sodium output
(m mil / Kg / day)
2.6
0.1
0.2
TOTAL 2.9 2.09
The  normal  plasma osmolality  is  275 – 290 m Osm/kg.   The  normal 
plasma sodium is 135 -145 mEq/L.  The plasma osmolality is chiefly determined 
by plasma sodium concentration.  The osmolality is normally maintained within 
narrow limits by appropriate variations in water intake and excretion.  This is 
governed by osmo-receptors in the hypothalamus which influences both thirst 
and ADH secretion.
THIRST 
Thirst is a subjective sensation that culminates in drinking.  Thirst may be 
triggered by osmotic and non-osmotic stimuli. 
Osmotic regulation of thirst
The  osmo-receptors  for  the  thirst  are  situated  in  anterolateral 
hypothalamus, close to the receptors that regulate AVP release25.  Changes in 
tonicity (effective osmolality) stimulate thirst.   When tonicity exceeds 290 m 
Osm/kg, thirst first appears.  This threshold is about 10 m Osm higher than that 
for vasopressin release..  Stimulus for thirst is slightly blunted in elderly.
Non-osmotic regulation of thirst
Non-osmotic  stimuli  for  thirst  include  social  practices,  pharyngeal 
dryness or decrease in volume of extra-cellular fluid independent to alteration of 
tonicity  of  extra-cellular  fluid.   Decreases  in  extra-cellular  fluid  volume 
stimulate thirst via rennin-angiotensin system.  Angiotensin-II acts as a probable 
mediator by its dipsogenic effect25, 28.  Other dipsogens include antidepressants, 
β-adrenergic and cholinergic agents.
In  elderly  person,  there  is  blunted  thirst  response  to  hyper-osmolality 
resulting in hypernatermia.  Psychogenic polydipsia may be seen in psychiatric 
patients.
Anti-diuretic Hormone, Arginine Vasopressin
Arginine Vasopressin (AVP) is a non-peptide synthesized in supra-optic 
and para-ventricular  nuclei  of  hypothalamus.   It  moves  via  neutral  axons  to 
posterior  pituitary  where  it  is  stored as  granules  and released in  response to 
stimulus29.  The pro-hormone is called pro-pressophysin and it is proteolysed in 
posterior pituitary to AVP.  It plays a pivotal role in water homeostasis by its 
action on most distal segment of the nephron.
Structure of AVP
AVP is a nona-peptide.  The presence of basic amino acid arginine is 
crucial for anti-diuresis.  The secretory process involves extrusion by exocytosis 
coupled to cellular uptake of calcium.
Figure 1
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Release of AVP
Vasopressin is released from posterior pituitary in response to osmotic 
and  non-osmotic  stimuli.   The  plasma  level  of  AVP  detected  by  radio-
immunoassay  is  about  2.5  pg/ml  at  normal  plasma  osmolality  of  285  m 
Osm/kg25.
Osmotic regulation of Vasopressin
Osmo-receptors for AVP release are in hypothalamus close to receptors 
for thirst.  These osmo-receptors are more sensitive to change in osmolality.  A 
change of  osmolality  of  even one percent  of  normal  osmolality  brings  about 
significant change in circulating AVP levels25, 27.
AVP is suppressed below plasma osmolality of 280 m Osm/kg.  With fall 
in levels  of AVP kidneys produce maximally dilute urine.   When osmolality 
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rises,  plasma  AVP  levels  rise  in  a  linear  fashion  causing  production  of 
concentrated urine.
Factors  affecting  osmotic threshold for vasopressin release are  nature of 
osmotic  particle,  genetics,  age,  intravascular  volume  and  drugs.   Urea  is 
permeable and has no effect.  In absence of insulin, glucose is impermeable and 
may exert an osmotic effect.  Ageing, hypocalcaemia and lithium increase the 
sensitivity of osmo-receptors whereas tegretol, pregnancy slightly decrease its 
sensitivity29.
Non-osmotic regulation of vasopressin 
Decrement  in  pressure  or  plasma  volume  causes  prompt  secretion  of 
AVP.  Non osmotic regulation requires a change of up to 7 – 10%30, 31.  But once 
non-osmotic  release  of  ADH  has  been  started,  it  overrides  the  osmotic 
modulation.  By this mechanism, there will be continued secretion of ADH in 
hypovolemia.  Non osmotic stimuli  trigger ADH release through volume and 
baro-receptors located in aortic arch, carotid sinus and atria connected via para-
sympathetic  afferentS30,31.   Other  stimuli  like  nausea,  pain,  stress,  hypoxia, 
drugs32, 33 can stimulate ADH secretion34.
Renal regulation of water excretion
Nephron is the functional unit of kidney.  It is composed of glomerulus, 
proximal  tubule,  loop of  Henle,  distal  convoluted tubule  and collecting duct. 
Blood is filtered in the glomerulus producing ultra filtrate at the rate of  100 – 
125 ml/min.  This is known as glomerular filtration rate. 
In  the  proximal  convoluted tubule 70% is  reabsorbed passively.   This 
does  not  contribute  to  water  regulation  which  is  done  in  the  remainder  of 
nephron.
The  loop  of  Henle,  which  is  in  juxta-position  with  vasa  recta  enable 
nephron to produce hypotonic  tubular  fluid with hypertonic  interstitium with 
potential for formation of concentrated urine.  The loop of Henle and vasa recta 
have a counter current design and fluids flow in opposite directions.  The loop of 
Henle is a countercurrent multiplier, which relies on energy dependent transport 
and formation osmotic gradient.
The descending limb is permeable to solutes and water, allowing water to 
move outward into the hypertonic interstitium.  The entry of solutes into the 
descending limb from interstitium is by simple osmotic forces.  The ascending 
limb is impermeable to water and in thick ascending limb, there is co-transport 
of sodium, potassium and chloride.  The combination of impermeability of water 
and  outward  movement  of  solutes  produces  a  hypotonic  fluid  in  tubule  and 
hypertonic  interstitium and created the  gradient  for  countercurrent  multiplier. 
The vasa recta by removal of water and preventing loss of solute maintain the 
hypertonic intersititum.  
The fluid in distal convoluted tubule is always hypotonic regardless of the 
tonicity of final urine.  Another important site of water regulation is collecting 
ducts.  In absence of ADH, the collecting ducts are impermeable to water and 
hence osmotic equilibration between tubular fluid and hypertonic interstitium 
does not occur, resulting in maximally dilute urine.  In the presence of ADH, 
collecting duct becomes highly permeable to water and osmotic equilibration 
producing  concentrated  urine.   The  collecting  ducts  ultimately  determine 
whether the kidney is producing dilute or concentrated urine.
Mechanism of action of vasopressin
Vasopressin  binds  to  specific  receptor  on  baso-lateral  membrane  of 
collecting duct epithelial cells.  A pair of  G-protein receptors causes an increase 
in  cyclic  AMP  level.   This  stimulates  protein  kinase  which  causes  intra-
membranous particles to aggregate.  These particles are called as aggrephores 
and act as water channels to increase permeability26.
Figure – 2 
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To  summarize,  excretion  of  maximally  dilute  (<100mOsm/kg) 
urine,concentrated(1200mOsm/kg) urine requires an adequate GFR and delivery 
of fluid to functioning  distal sites and functioning of ADH.  
PATHOPHYSIOLOGY OF HYPONATREMIA
Sodium  is  the  major  osmotically  active  extra-cellular  cation.   Under 
normal  circumstances,  the  body  regulates  plasma  sodium  concentration  by 
adjusting the  water  content  in  ECF.   Despite  wide fluctuations  in  water  and 
sodium intake, the plasma concentration of sodium is maintained within normal 
range.  The integrated role of thirst, vasopressin and renal response maintain this 
tight  balance  between  sodium  and  water33,34,35.   Therefore,  hyponatremia  is 
almost always due to a defect in water balance.The kidneys play a key role in 
water homeostasis36 by the countercurrent mechanism38.
The distal convoluted tubule which is relatively impermeable to water, 
does active reabsorption of sodium.  The collecting duct is the site of osmotic 
equilibration,  which  is  mediated  by  vasopressin.   Water  channels  called 
aquaporins,  in  the  collecting duct  cells  facilitate  the  rapid transport  of  water 
c-AMP
Protein kinase Activation
Increased Permeability
across cell membranes39.  Ten separate aquaporins have been identified so far, 
and at least six are known to be present in the kidney  along the nephron and 
collecting duct40,41.   Aquaporin-2 has been shown to be a vasopressin dependent 
water channel controlling collecting duct water permeability42.  The binding of 
arginine  vasopressin  to  its  V2  receptor  in  the  collecting  duct  principal  cell 
initiates  cAMP-mediated  phosphorylation  of  the  aquaporin-2  water  channel. 
This  results  in  translocation  of  aquaporin-2  containing  vesicles  from  their 
cytosolic  location  to  the  apical  membrane  of  the  collecting  duct,  thereby 
allowing  the  passive  movement  of  water  from  tubule  fluid  to  medullary 
interstitium  along  the  osmotic  gradient  crerated  by  the  countercurrent 
concentrating  mechanism43.  The  mineralocorticoid  Aldosterone  also  increases 
net  sodium re-absorption through its  action on the collecting tubules.   Atrial 
natriuretic  peptide  inhibits  sodium  re-absorption  ,  causing  natriuresis  and 
diuresis44.  Glucocorticoids45, glucagon46, calcitonin47 and prostaglandins48 may 
all modify the effect of vasopressin at the renal tubular level.
Pathogenesis of hyponatremia
The normal components of the renal diluting mechanism are depicted in 
Figure-349.  Hyponatremia results from disorder of this diluting capacity of the 
kidney in the following situations.
Figure 3
1. Intra-renal factors such as a diminished GFR or an increase in proximal 
tubule fluid and sodium re-absorption can decrease distal delivery to the 
diluting  segments  of  the  nephron.   This  is  seen  in  volume  depletion, 
congestive heart failure, cirrhosis or nephrotic syndrome.
2. A defect in sodium chloride transport out of the water impermeable thick 
ascending limb of the loop of Henle occurs in patients with interstitial 
renal disease or in patients on diuretics.
3. Continued  secretion  of  ADH  despite  the  presence  of  serum  hypo-
osmolality mostly stimulated by a non-osmotic mechanism.
Classification of Hyponatremia
A very practical approach is to classify hyponatremia on the basis of ECF 
volume status into hypovolumic, euvolumic or hypervolumic hyponatremia50,51. 
This classification is useful in making an appropriate diagnosis and designing 
effective treatment of hyponatremia.
Pseudo-hyponatremia
Pseudo-hyponatremia  is  an  artificial  reduction  in  plasma  sodium 
concentration in the presence of marked elevation of plasma proteins or lipids. 
Measurement of plasma sodium with ion-specific electrodes instead of  flame 
photometry may alleviate this problem52,53.
Hypovolumic hyponatremia
Loss of both sodium and water either through the kidneys, gastrointestinal 
tract  or  skin  can  lead  to  ECF volume  depletion.  The  resultant  hypovolumia 
stimulates vasopressin secretion, impairing renal free-water excretion.  In this 
setting,  excessive oral  or  parenteral  hypotonic  fluid intake can lead to  water 
retention and eventual hyponatremia.  Hyponatremia is a common complication 
of diuretic therapy.  Thiazide diuretics are the commonest cause of hypovolumic 
hyponatremia.   Besides  hypovolumia,  thiazide  diuretics  may  precipitate 
polydipsia  along  with  decreased  urinary  dilutional  capacity,  as  shown  by 
Freidman  et  al54.   Hyponatremia  secondary  to  diuretics  is  multi-factorial. 
Excessive renal sodium loss,  vasopressin stimulation and potassium depletion 
are the most important mechanisms.  Hyponatremia due to thiazides is generally 
seen within two weeks of initiating therapy56.  The presence of hyponatremia, 
hypokalemia,  metabolic  alkalosis,  hypomagnesaemia  and  increased  fractional 
excretion of potassium is suggestive of diuretic induced hyponatremia.
In adrenal insufficiency, salt depletion is due to excessive urinary sodium 
loss  from  aldosterone  deficiency,  which  causes  a  reduction  of  intravascular 
volume  that  stimulates  vasopressin  secretion  through  baro-regulatory 
mechanisms57.  A further increase in vasopressin secretion results from gluco-
corticoid deficiency.
In  an  intensive  care  setting,  cerebral  salt  wasting  syndrome  is  not 
uncommon.  First  described by Peters et  al58,  this entity was eclipsed by the 
syndrome of inappropriate anti-diuretic hormone secretion.  There is evidence to 
indicate  that  cerebral  salt  wasting  syndrome  is  seen  in  many  patients  with 
intracranial  disease  such  as  stroke,  head  injury,  sub-arachnoid  hemorrhage, 
cerebral  tumors.   Cerebral  salt  wasting  syndrome  is  characterized  by 
hyponatremia,  hypovolumia,  natriuresis  and  dieresis59.   The  mechanism  by 
which intracranial disease leads to cerebral salt wasting syndrome is not well 
understood.  The postulated mechanism include disruption of neural input into 
the kidney or the central elaboration of a circulating natriuretic factor or both59,60. 
Cerebral salt  wasting syndrome usually resolves spontaneously within two or 
three  weeks  of  cerebral  insult  and  responds  well  to  prompt  treatment  with 
intravenous saline61.
Euvolumic Hyponatremia
In euvolumic hyponatremia, the body water content is increased with a 
normal  to  mild decrease  in  total  body sodium.   In  most  cases  of  euvolumic 
hyponatremia, the intravascular volume is normal.  Post-surgical hyponatremia 
is  frequently  seen in  hospitalized patients  and it  is  iatrogenically  induced by 
inappropriate hypotonic fluid replacements.  Elevated levels of vasopressin in 
the  post-operative  period  prevent  free-water  excretion,  resulting  in 
hyponatremia.   Euvolumic  hyponatremia  can  be  due  to  translocation 
hyponatremia,  SIADH,  hypothyroidism,  adreno-corticotropin  deficiency  or 
primary polydipsia.
Translocation hyponatremia
It results from a shift of water from cells to the ECF that is driven by 
solutes  confined  in  the  extracellular  compartment62.   It  occurs  with  glucose, 
mannitol50, sorbitol, glycerol and radio-contrast agents and is called translocation 
hyponatremia.  Poor glycemic control accounts for hyponatremia in 10% to 20% 
of the hospitalized patients9.  Hillier et al proposed a correction factor of 2.4 
mEq/L  decrease  in  sodium concentration  per  100  mg/dl  increase  in  glucose 
concentration63.  This factor is better than the usual correction factor of 1.6 in 
mEq/L.  Translocational hyponatremia is seen following transurethral resection 
of prostate and endoscopic uterine surgeries.  It is mainly due to absorption of 
irrigating fluids used during this procedures64,65.
Syndrome of inappropriate anti-diuretic hormone secretion
SIADH is an important cause of hyponatremia that occurs when normal 
control of   secretion is lost and ADH is secreted independently of the body’s 
need  to  conserve  water.  ADH causes  water  retention,  so  hyponatremia  then 
occurs as a result of inappropriately increased water retention in the presence of 
sodium  loss51.   The  hyponatremia  in  SIADH  secretion  results  from  either 
increased circulating vasopressin as seen in lung malignancies or from abnormal 
osmo-regulation  from a  ‘reset  osmostat’  for  vasopressin  secretion,  such  that 
vasopressin is released at an abnormally low threshold of plasma osmolality66,67. 
Another important factor that leads to hyponatremia in patients with SIADH is 
the abnormal increase in thirst68.  Patients with SIADH continue to drink normal 
amounts  of  fluid,  despite  plasma  osmolalities  well  below  the  physiological 
osmotic threshold for onset of thirst.  There is downward resetting of the osmotic 
threshold for thirst in SIADH69.
Causes  of  syndrome  of  Inappropriate  Anti-diuretic  Hormone 
Secretion35 
Central nervous system disorders
• Vascular diseases (thrombosis, embolism, hemorrhage, vasculitis), trauma 
(subdural  hematoma,  subarachnoid  or  intracranial  hemorrhage),  tumor, 
hydrocephalus,  infection (meningitis,  encephalitis,  brain abscess),Acute 
intermittent  porphyria,  Systemic  Lupus  erythematosus,  Postoperative 
transsphenoidal hypophysectomy, Schizophrenia
Neoplasms with ectopic hormone production
• Small-cell  carcinoma  of  the  lung,  Pharyngeal  carcinoma,  Pancreatic 
carcinoma,  Thymoma,  Lymphoma,  Hodgkin’s  disease,  reticulum  cell 
sarcoma, Bladder carcinoma
Pulmonary disease
• Pneumonia, Lung abscess, Bronchiectasis, Tuberculosis
• Endocrine disease
• Pituitary tumor, Hypothyroidism, Adrenal insufficiency
• Others
• Positive  pressure  ventilation,  Acquired  Immune  Deficiency  syndrome, 
Idiopathic SIADH of the elderly, Nausea, pain, psychosis
SIADH is diagnosed by following criteria
Essential criteria
1. Hypo-osmolality (plasma osmolality <270 m Osm/kg).
2. Inappropriately concentrated urine (>100 m Osm/kg).
3. Clinical euvolumia.
4. Elevated urine sodium (>40 mEq/L) with normal salt and water intake.
5. Euvolumia with normal adrenal, thyroid, renal and liver functions.
Supplemental criteria
1. Abnormal  water  load  test.   (Inability  to  excrete  at  least  90%  of  a 
20 mL/kg water load in 4 hrs or failure to dilute urinary osmolality to 
<100 m Osm/kg).
2. Plasma anti-diuretic  hormone level  inappropriately  elevated  relative  to 
plasma osmolality.
3. No significant correction of plasma sodium with volume expansion, but 
improvement after fluid restriction.
Hypothyroidism
The pathophysiology of hyponatremia in hypothyroidism is still unclear, 
as  both increased total  body sodium and increased plasma vasopressin levels 
have  been reported70.Reduced stroke  volume stimulates  vasopressin  release71. 
Decreased free-water excretion is suggested and supported by data from water 
loading studies in hypothyroid patients70.
Adreno-corticotrophin deficiency
Increased  plasma  levels  of  vasopressin  have  been  shown  in  adreno-
corticotrophin  deficient  patients  presenting  with  hyponatremia72 and  there  is 
evidence to suggest impaired free-water excretion73.
Primary polydipsia
Psychogenic  polydipsia  frequently  seen  in  psychiatric  patients  is 
secondary to excessive water intake74.  Plasma levels of arginine-vasopressin are 
partially suppressed in  these patients75. The dilutional ability of the kidney is 
overwhelmed by  excessive  water  intake.  In  patients  who  consume excessive 
amounts of beer, this is further exaggerated by poor caloric intake. 
Hypervolumic hyponatremia
It  is  characterized  by  clinical  evidence  of  volume  overload  with 
peripheral edema in  heart failure and cirrhosis.  There is an excess of total body 
sodium and water76.   A decrease  in  mean arterial  pressure  leads  to  resultant 
secondary  hyper-aldosteronism  which  causes  increased  distal  renal  tubular 
sodium  re-absorption  and  subsequent  increase  in  total  body  sodium. 
Simultaneously, there is a failure of normal physiologic escape from the anti-
natriuretic effect of   aldosterone78.  Thus, increase in total body water results 
from increased vasopressin concentration, causing up-regulation at aquaporin2 
water channels and further anti-diuresis79.
Cerebral adaptation to hyponatremia
When the  extra-cellular  osmolality  falls  water  starts  to  move  into  the 
cells.  This increases the intracellular volume and result in tissue edema.  This 
cellular edema when occur within the fixed confines of the cranium, it causes 
increased intracranial pressure, leading to neurological symptoms. To prevent 
this,  mechanisms  of  volume  regulation  come  into  operation  in  patients  with 
hyponatremia.  After induction of extra cellular fluid hypo-osmolality, free water 
moves into the brain in response to osmotic gradients, producing cerebral edema 
(bottom panel).   However,  within  one to  three  hours,  a  decrease  in  cerebral 
extra-cellular volume occurs by movement of fluid into the cerebrospinal fluid, 
which is then shunted back into the systemic circulation.  This happens very 
promptly and is evident by the loss of extra-cellular and intracellular solutes as 
early  as half  an hour after the  onset  of hyponatremia.   As the  loss of  water 
accompany the loss of brain solute (middle panel) the expanded brain volume 
decreases back towards normal (upper panel).
CLINICAL FEATURES
Clinical symptoms of hyponatremia vary from individual to individual49. 
Hyponatremia is defined as a serum sodium concentration less than 135 mEq/L7, 
8, 50,51,80,81,82,83,84.
Hyponatremia  is  not  a  disease  in  itself  ,85it  is  frequently  a  marker  of 
significant  underlying  disease86.  Patients  in  whom  the  serum  sodium 
concentration is greater than 130 mEq/L are usually asymptomatic.  The severity 
of symptoms increase with the degree of fall in serum sodium level and rapidity 
with which the fall occurs89.   Several factors other than fall in serum sodium 
contribute to the symptomatology like extremes of age, female sex, underlying 
systemic diseases .  Patients in hypoxia, acidosis and hypercapnia may be more 
symptomatic49.   Initially  symptoms  of  hyponatremia  are  gastrointestinal 
symptoms.   Symptoms occurring early in hyponatremia are usually  anorexia, 
nausea and vomiting.  Some patients may have headache and irritability.  As 
serum sodium level falls  further patients  develop neuropsychiatric symptoms. 
These  symptoms  range  from  restlessness,  altered  consciousness,  gait 
disturbances, lethargy, obtundation, myoclonic jerks, seizures, status epilepticus 
to coma49,90,91,92,93.  Some patients may develop muscle cramps and weakness on 
exertion94.  Severe and rapidly evolving hyponatremia may present with seizures, 
coma,  permanent  brain  damage,  respiratory  arrest,  brainstem  herniation  and 
death88.  Hyponatremia is a major cause of brain damage, dementia and death 
among  hospitalized  patients  and  its  coexistence  with  other  major  medical 
illnesses  (heart  failure,  myocardial  infarction,  tuberculosis,  cirrhosis)  increase 
overall in-hospital mortality by at least six fold95.
The symptoms vary with acute and chronic hyponatremia.  When serum 
sodium falls gradually, over a period of several days or weeks, patients will have 
minimal  symptoms.   This  is  due  to  the  cerebral  adaptation  occurring  in 
hypernatremia.  These include a gradual loss of intracellular osmolytes, lowering 
the osmotic gradient between the blood and the brain96.  When serum sodium 
falls over 24 – 48 hours, it overwhelms the above compensatory mechanisms. 
This leads to severe cerebral edema and symptoms6,97.
The physical findings are dependent on the degree and the chronicity of 
hyponatremia.   Most  abnormal  findings  on  physical  examination  are 
neurological in origin94,98,99.
Patients  with  hyponatremia  may  have  symptoms   of   an  underlying 
disease.   Various  studies9,100,101 has  shown  association  of  hyponatremia  with 
pulmonary and central nervous system diseases.  So, the clinician should have 
suspicion of hyponatremia in patients with respiratory symptoms suggestive of 
pneumonia,  pulmonary  tuberculosis,  pulmonary  abscess,  bronchiectasis, 
malignancies  and  chronic  obstructive  pulmonary  disease.   Patients  with 
symptoms  suggestive  of  central  nervous  system  infections,  trauma,  vascular 
accidents or tumors should be evaluated12.  Hyponatremia may complicate the 
clinical course of many acute neurologic and neurosurgical disorders84.
Evidence  for  malignancy  should  be  looked  for  in  every  patient. 
Hyponatremia associated with malignancies may be secondary to ectopic anti-
diuretic hormone secretion or chemotherapy or undercurrent infections.
Many drugs alter the sodium metabolism.  Individuals who are on these 
medications have preponderance to develop hyponatremia54.  History related to 
drug  intake  is  essential.   Drugs  such  as  amiodarone,  lisinopril,  digoxin, 
chlorpropamide,  tolbutamide,  desmopressin,  clofibrate,  clozapine,  theophiline, 
carbamazepine, opiates, oxytocin, thiazides, prostaglandin synthesis inhibitors, 
nicotine, phenothiazines, selective serotonin re-uptake inhibitors, antipsychotics, 
tricyclic antidepressants, trazodone, vincristine, cyclophophomide and NSAID’s1 
are known to cause hyponatremia35.
Patients with history of persistent vomiting and diarrhea, on inadequate 
parenteral nutrition and reduced dietary intake can develop hyponatremia.  These 
patients  are usually  dehydrated or volume depleted and they tend to  develop 
hypovolumic hyponatremia.  Clinically these patients present with features of 
hypovolumia  like  dry  mucous  membranes,  sunken  eyes,  tachycardia  or 
orthostatic hypotension12.  A study done by Kende M et al over a period of two 
years at Port Moresby General Hospital observed that hyponatremia was higher 
among  patients  with  diarrhea  and  vomiting11.   Lee  et  al  noticed  that  all 
commonest cause for hyponatremia was gastrointestinal diseases. 
Hyponatremia  should  also  be  suspected  in  patients  with  symptoms  of 
congestive  cardiac  failure77,78,  renal  failure  and  cirrhosis.   Even  mild 
hyponatremia was significantly associated with the higher mortality of patients 
with  stable  CHF.   Persistent  hyponatremia  have  a  higher  risk  of  events  in 
patients with heart failure than normonatremic patients despite similar clinical 
improvements.  Patients with above mentioned clinical diseases are mostly on 
diuretic therapy and so, are at increased risk of developing hyponatremia.  These 
patients  are  usually  over-loaded  with  fluids  and  will  have  clinical  features 
suggestive  of  fluid  excess,  such  as  pulmonary  basal  crepitations,  S3  gallop, 
peripheral edema or ascites.
Patients  with  hyponatremia,  who  lack  findings  of  hypovolumia  or 
hypervolumia,  are  considered  to  have  euvolumic  hyponatremia.   Euvolumic 
hyponatremia is seen in patients with etiologies like exogenous free water load, 
hypothyroidism70,71 cortisol deficiency73, hypo-pituitarism72 or SIADH9.
Patients with viral, bacterial,  protozoal, mycoplasmal,  fungal infections 
are predisposed to hyponatremia.  So an index of suspicion for hyponatremia is 
essential in patients with these infections.  Hyponatremia occurs commonly in 
patients  with AIDS and is  associated with higher  morbidity  and mortality  in 
these patients.  
Among hospital in-patients use of hypotonic fluids and in post-operative 
patients are at risk for hyponatremia mostly due to improper fluid management 
or irrigating fluids64,65. 
Psychiatric  patients  are  prone  to  develop  hyponatremia  either  due  to 
medications or to polydipsia74,75.  Hyponatremia can also exacerbate psychiatric 
symptoms.35 Persons  with  substance  abuse  as  MDMA 
(3,4  methylenedioxymethamphetamine)10,  diamorphine  can  develop 
hyponatremia.  Hyponatremia is reported in marathon runners and athletes due to 
loss of solutes.  Hyponatremia is known to occur among alcoholics.  
Rhabdomyolysis  is  an  occasional  consequence  of  hyponatremia  and 
should  be  considered  in  patients  with  muscle  pain  or  tenderness.   Seasonal 
variation was noted with the occurrence of hyponatremia.  This was probably 
due to variations in the ambient temperature influencing insensible fluid losses 
that could possibly have altered hydration status and sodium balance.
The prognosis of hyponatremia is usually proportional to the severity of 
their co-morbid conditions.  However, it is difficult to ascertain if the electrolyte 
disturbances is the primary cause of the increased morbidity, or whether it is due 
to the underlying conditions.
The  severity  of  symptoms and signs  are  generally  more  prominent  in 
elderly patients due to their failure of homeostatic mechanisms.  It can also be 
explained by the increase in use of sodium lowering drugs in the elderly such as 
selective serotonin reuptake inhibitors for depression, or thaizide diuretics for 
hypertension and secondary prevention of stroke.
Rapid recognition and optimal treatment of depressed serum sodium can 
reduce the risk of death and symptom severity, permit less intensive care, reduce 
the duration of hospitalization and associated costs, increase success in treatment 
of underlying co-morbid conditions, and improve quality of life35.
DIAGNOSTIC APPROACH TO HYPONATREMIA
Serum osmolality
The initial approach to a hyponatremia patient is to measure the serum 
osmolality  to  determine  if  the  hyponatremia  represents  a  true  hypo-osmolar 
state.  Thus, in a patient with hyponatremia, normal or elevated effective serum 
osmolality  suggests  the  presence  of  either  pseudohyponatremia  or  increased 
concentration of other osmoles, such as glucose and mannitol62.
In  the  context  of  marked  hyperlipidemia  (hyper-triglyceridemia)  and 
lactescent  serum,  lipids  occupy  a  significant  space  in  the  volume  of  serum, 
leading to lower readings in the concentration of sodium and free water per litre 
of serum.  But physiologically the serum osmolality, the amount of water and 
concentration of sodium in serum remain unaffected.  Newer methods using ion-
selective electrodes in the measurement of serum electrolytes may avoid this 
problem.
In the presence of osmotically active substances (e.g., hyperglycemia or 
mannitol infusions), an increase in serum osmolality is observed, which results 
in movement of water out of the cells and subsequently a reduction of the serum 
sodium level by dilution.  It has been calculated that every increase of 3.4 m 
mol/L in the serum glucose level will  draw enough water out of the cells to 
reduce  the  serum  sodium  concentration  by  1  m  mol/L.   However,  recent 
evidence  suggests  that  the  hyperglycemia  induced  decrease  in  sodium 
concentration is considerably higher than the “standard” correction factor of 1.6, 
especially  when  glucose  levels  are  greater  than22.2  m  mol/L.   Hillier  and 
colleagues63 have proposed that a correction factor of 2.4 m mol/L is a better 
overall estimate of the association between sodium and glucose levels.
Urine osmolality
If  a  hypo-osmolar  state  is  confirmed,  the  next  step  is  to  determine 
whether the ability of the kidney to dilute the urine is intact by measuring urine 
osmolality158.  The normal response of the kidney is to excrete maximally dilute 
urine.  If urine is maximally dilute, it indicates that anti-diuretic hormone (ADH) 
secretion is completely and appropriately suppressed, a finding seen in patients 
with primary polydipsia or reset osmostat syndrome62.  Hyponatremia is unlikely 
to  develop  in  the  setting  of  an  intact  urine  diluting  mechanism.   However, 
Gillium et al reported patients who ingest large amounts of water, in isolated 
instances of more than 10 to 15 liters per day can develop hyponatremia.  In 
these cases, a tendency to hyponatremia will be unmasked and enhanced by a 
concurrent  impairment  in  water  excretion.   This  can  occur  in  the  setting  of 
central nervous system dysfunction and in antipsychotic agents, or it may be due 
to nausea or stress induced ADH secretion.  Another unusual situation, in which 
modest amounts of fluid intake can lead to hyponatremia even when the urine 
diluting ability is intact, is observed in cases of extremely reduced solute intake. 
In these patients, the ability to excrete water is reduced by a poor dietary intake 
of  salt.   This  phenomenon  has  been  described  in  patients  with  chronic 
alcoholism and is often referred to as “beer potomania syndrome”.
Urine sodium concentration
In patients with hyponatremia, it is particularly important to assess the 
effective arterial blood volume.  A decreased in blood volume is by far the most 
common cause of hyponatremia in clinical practice.
Hypovolumia can be determined clinically, by the presence of postural 
changes  in  blood  pressure  and  pulse  rate.   Measurement  of  volume  and 
electrolyte  level  in  urine  is  extremely  useful  in  the  assessment  of  effective 
arterial  blood  volume.   Patients  with  volume  depletion  exhibit  low  urinary 
excretion of sodium and chloride (sodium level less than 20 m mol/L., chloride 
levels less than 20 m mol/L).  An urine sodium level of less than 20 m mol/L in 
hypovolumia is relevant if renal salt wasting does not exist.  On the other hand, 
an increased urine sodium level, a level above 40 m mol/L is usually observed in 
patients with euvolumic hyponatremia.  In individuals with low dietary intake of 
salt, the urine sodium concentration in euvolumic hyponatremia may be less than 
20 m mol/L.
An increased urine sodium concentration, greater than 40 m mol/L, is also 
found in sodium wasting condition, such as recent diuretic therapy, certain renal 
parenchyrnal  diseases,  adrenal  insufficiency  and  metabolic  alkalosis. 
Hyponatremia  is  common  with  thiazide  diuretics,  which  act  on  the  distal 
convoluted tubule by interfering with dilution of urine.
The  ability  of  the  kidney  to  conserve  sodium and  dilute  the  urine  is 
impaired in patients with progressive renal disease owing to associated osmotic 
diuresis.  However, the capacity of water excretion is relatively maintained in 
mild to moderate renal disease.  Water retention and hyponatremia are seen only 
when the glomerular  filtration rate falls  to very low levels.   In  patients  with 
chronic renal failure, salt wasting seems to occur only after acute reductions in 
salt intake.
In  metabolic  alkalosis  related  to  volume  depletion,  urinary  chloride 
excretion  is  low,  to  less  than  10  to  20  m  mol/L,  owing  to  increased  renal 
reabsorption of chloride.  So, determination of the urine chloride level may help 
and this index is sometimes preferred to the urine sodium level as a measure of 
extra cellular volume.
In  patients  with  urine  sodium levels  between  20  to  40  m mol/L,  the 
response  of  serum  sodium  and  its  fractional  excretion  (FE-Na+  )  to  the 
administration of normal saline (one to two liters per day for one to two days) 
can be used to establish a correct diagnosis.  An increase of less than 5 m mol/L 
in serum sodium levels and an increase of greater than 0.5% in FE-Na+ is highly 
suggestive of SIADH, whereas an increase in serum sodium levels greater than 5 
m mol/L and an increase of less than 0.5% in FE-Na+ is evident in patients with 
hypovolemia.
Evaluation  of  causes  of  the  syndrome  of  inappropriate  diuretic 
hormone secretion      
Patients with hyponatremia due to SIADH may require radiological and 
sonological  assessment  to  rule  out  pulmonary,  central  nervous  system  and 
gastrointestinal diseases or disorders.
Hormonal disorders
It is of interest that the sodium concentration may be low, as much as 130 
m mol/L,  in pregnant women.  This is due to human chorionic-gonadotropin 
hormone induced release of  relaxin.   Relaxin is  associated with a downward 
resetting of serum osmolality.
Hyponatremia can occur in the setting of primary or secondary adrenal 
insufficiency  and  hypothyroidism.   Therefore,  serum  levels  of  thyroid 
stimulating  hormone  and  random  cortisol  should  be  determined  in  cases  of 
hyponatremia before a diagnosis of SIADH is made.  Gluco-corticoid deficiency 
increases water  permeability  in  the collecting tubules.   Elevated ADH levels 
have been found in patients with gluco-corticoid deficiency.  In patients with 
hypothyroidism,  both  ADH-mediated  and  intra-renal  mechanism  have  been 
implicated in the pathogenesis of hyponatremia.
Acid-base status and potassium homeostasis
Acid-base status and potassium balance should be evaluated in certain 
cases of hyponatremia.  For example, the presence of metabolic acidosis and 
hyperkalemia  is  suggestive  of  renal  functional  impairment  or  adrenal 
insufficiency,  whereas  a  diarrhoeal  syndrome  is  usually  associated  with 
metabolic acidosis and hypokalemia.  Excessive vomiting or the use of diuretics 
may  result  in  hyponatremia  in  association  with  metabolic  alkalosis  and 
hypokalemia.   However,  acid  base  status  and  potassium  balance  are  not 
disturbed  in  SIADH.   Additional  electrolyte  abnormalities  which  include 
hypophosphatemia,  hypokalemia  and hypomagnesemia are  frequently  seen in 
hyponatremic patients, independently of hyponatremia cause.  
ALGORITHM TO DIAGNOSE HYPONATREMIA
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MATERIALS AND METHODS
Study area
Madras Medical College and Government General Hospital is one of the 
largest  hospitals  in  South  India  located  in  Chennai  Metropolis,  Tamil  Nadu 
catering the needs of over one crore people.
The Laboratory
The Biochemistry lab is a standardized laboratory.  The methods used for 
estimation are:
Methods →  1.  Serum Sodium – HILITE/Transaminase
2.  Serum Potassium – I.S.ELECTRODE (Ion selective 
Electrophoresis) 
3.  UREA – Glutaraldehyde LDH
                          4.  Creatinine – Jaffe Kinetic 
5.  SUGAR – (GOD/POD/Glucose oxidase peroxidase)  
6.  LFT – Enzymes – kinetic
7.  TFT – Automated ELISA reader
8.  Urine Na – I.S.ELECTRODE
9.  Urine K – I.S.ELECTRODE
         10.  Lipids – ENZYMATIC METHOD
         11.  Urine osmolality – FREEZING POINT METHOD  
Study Population
Patients admitted in Government General Hospital  medical  wards with 
serum sodium less than 130 mmol/L.
Type and duration of study
Cross section study, period of one and a half year (January 2008 to June 
2009).
Inclusion Criteria
All  inpatients  >12 years of  age with atleast  two serum sodium values 
<130 mmol/L.
Exclusion Criteria
Patients with age less than 12 years and patients who are treated with 
Mannitol and  osmotic diuretics.
Sample size and Technique
One hundred patients of Government General Hospital,Chennai.
The lab values of serum sodium of all patients from January 2008 to June 
2009 was studied from which incidence of hyponatremia was calculated.
Out  of  this  hyponatremic patients,  a  sample  size of  100 patients  were 
randomly selected by SIMPLE RANDOM SAMPLING, FROM THE TABLE 
OF RANDOM NUMBERS  satisfying the inclusion criteria.
Data collection technique
In the hospital, all the patients’, as routine, blood samples were taken and 
serum electrolytes were done in central biochemistry laboratory.  The records 
were followed up for patients with hyponatremia and values repeated once for 
confirmation.
A standard proforma was used to record to detailed history of present 
complaints,  past  history  including  diabetes  mellitus,  systemic  hypertension, 
Ischemic  heart  disease,  dyslipidemia,  neurological,  chronic  kidney  disease  / 
renal disease, regulatory and endocrine problems.  A detailed drug history was 
also recorded.
Findings  on  clinical  exam  including  volume  status  of  patients  were 
recorded.
Based on investigations and management of a patient, the following data 
was recorded.
Initial serum, sodium, final sodium at discharge/death, calculated serum 
osmolality, urine osmolality, urine spot sodium and endocrine work up (as and 
when required) were done.
The fluid management and drugs, if used were also noted.
The probable cause was correlated and the outcome of hospitalization was 
recorded.
STATISTICAL ANALYSIS
DESCRIPTIVE STATISTICS
The descriptive statistics – mean, median, standard deviation, minimum 
value, maximum value, range was used to describe the data.
1. Central tendency (Average)
a. Arithmetic Mean (X)
b. Median
c. Mode
2. Measures of dispersion 
a. Range
b. Standard deviation 
The mean and standard deviation are  calculated.   The values  between 
(a)  1 standard deviation on either side of mean  will  include 68% of values 
(b)  values  of  twice the  standard  deviation  from the mean will  have 95% of 
values .These are “Confidence limits” of mean.
The data was entered into excel work sheet and above calculated. 
OBSERVATION AND RESULTS
The total number of hospital admission in medical wards was 25,326 and 
serum sodium estimates was done for 21,020 patients.  The number of patients 
with hyponatremia less than 130 mmol/L was about 3980 patients (18.9%).  The 
number  of  patients  with  severe  hyponatremia  with  serum  sodium  less  than 
120 mmol/L was 620 patients (2.95%).
Distribution of serum sodium levels among all inpatients (21,020)
TABLE 4
Range No. of patients
>145 420
136 – 145 14714
131 – 135 1892
120 – 130 3384
<120 610
Total 21020
Out of the 21,020, 100 patients were selected.  The observations arrived out of 
the 100 patients were as follows:
TABLE 5
Numbers (n=100)
Males 57
Females 43
Age
Mean age of patients admitted was 62.46 years.  Youngest age was 18 
years old.  The oldest age was 88 years.  
TABLE 6
Range No. of patients
15 – 25 2
26 – 35 2
36 – 45 7
46 – 55 20
56 – 65 22
66 – 75 29
76 – 85 17
86 – 95 1
Total 100
Hyponatremia development at admission/emergency ward/wards/
IMCU
92 patients had hyponatremia in wards.
Mode of admission
93% of patients prevented to emergency room with hyponatremia.
Admission to Intensive Care Unit
36%  of  patients  were  also  admitted  in  IMCU  and  found  to  have 
hyponatremia.
Co-morbid conditions
There  were  common  chronic  diseases  with  three  patients  like 
hypertension and diabetes mellitus.
Associated Chronic Diseases
TABLE 7
Disease Percentage (%)
Psychiatric disorders 3
Chronic kidney disease 6
Adrenal insufficiency 10
Gastrointestinal 13
Hypothyroidism 16
Respiratory problem 18
Renal problems 19
Others 25
Cardiac problem 31
Diabetes Mellitus 55
Hypertension 58
Drugs causing hyponatremia
29% of patients  were on diuretics  and 42% of patients were on drugs 
other than diuretics which causes hyponatremia.
 TABLE 8
Percentage (%)
On Diuretics 29
Other than Diuretics 42
Symptoms
67  patients  had  some  neurological  symptoms  of  hyponatremia  due  to 
cerebral  edema  like  nausea,  vomiting,  giddiness  and  altered  sensorium.   14 
patients presented with seizures.
The  lower  the  sodium value,  the  higher  the  incidence  of  lymptamatic 
hyponatremia. 
TABLE 9
Symptoms No. of patients
Neurological symptoms 
(Nausea, vomiting, 
giddiness, etc.,)
67
Altered Sensorium 43
Seizures 14
Symptoms – level of hyponatremia
TABLE 10
Range (n=10) Symptomatic Asymptomatic P value
<110 10 0 <0.001
110 – 120 40 (71%) 16 <0.05
120 – 130 17 (50%) 17 0.32
The  incidence  of  symptomatic  hyponatremia  is  more  with  lowering 
sodium  levels  which  is  statistically  significant.   All  patients  with  severe 
hyponatremia had symptoms.
VOLUME STATUS
TABLE 11
Volemic status No. of patients
Hypervolemic 19
Hypovolemic 19
Euvolemic 62
TABLE 12
SYMPTOMS ACCORDING TO VOLUME STATUS
Volume Status
( n = 100)
Symptomatic 
(%) 
Asymptomatic 
(%)
P value
Euvolemia 47 15 P<0.05
Hypervolemia 7 12 P = 0.46
Hypovolemia 13 6 P = 0.21
Most  of Euvolemic patients  were symptomatic (P<0.05).   Most  of the 
Hypervolemic patients were asymptomatic and most of Hypovolemic patients 
were symptomatic.  
Initial sodium
The  mean  initial  sodium was  118.6mEq/L  with  standard  deviation  of 
5.4864.
Final sodium
The  mean  final  sodium was  122.53mEq/L  with  standard  deviation  of 
3.8755.
Laboratory investigations
All the 100 patients had calculated serum osmolality  done.  92 patients 
had  urine  osmlality  done.   78  patients  had  thyroid  function  tests  done.   53 
patients had serum cortirol / ACTH stimulation tests done.
16  patients  had  hypothyroid  problems.  10  patients  had  adrenal 
insufficiency. (by ACTH stimulation test (Adreno Cortico Typical Hormone).
Primary diagnosis
The primary diagnosis  as  per discharge/death summary is  tabulated as 
appendix.  The most common diagnosis was metabolic encephalopathy followed 
by cardiac failure.  Many patients has various infections.
TABLE 13
ETIOLOGY OF HYPONATREMIA
Cause of hyponatremia Frequency
SIADH 28
Addison's disease / adrenal insufficiency 6
Adrenal pituitary 1
Cerebral salt wasting Syndrome 1
Dehydration / adrenal insufficiency 1
Dehydration / hypothyroidism 1
Dehydration / hypovolemic 12
Dehydration and Hypovolemic 1
Dilutional hyponatremia 1
Diuretics 14
Hypothyroidism alone 9
Panhypopitutarism (Hypothyroid + adrenal insufficiency) 4
Post obstructive diuretics 1
Pseudohyponatremia 2
Renal failure 3
Renal failure and ascites (volume overload) 2
Renal failure and liver failure 1
Unclear cases 3
Volume overload 11

The commonest cause of hyponatremia was SIADH.  A lot of patients had 
endocrine causes.  Hypothyroidism, Addison’s and pituitary insufficiency.  
TABLE 14
TREATMENT
Type of Treatment Frequency
Normal Saline + Diuretics 43
Insulin, NS 1
NS+3% saline 5
Fluid restriction diuretics 4
Fluid restriction alone 1
3% saline 31
3% saline + diuretics 1
Dialysis 1
Steroids + NS 6
Diuretics 12

TABLE 15
CAUSES
No.of cases
Multifactorial causes 37
Cases unclear 4
Single cause 59
Ninety patients improved, but of which one went into extrapontine myelinolysis but 
recovered.  
Eight patients died
Two patients deteriorated / discharged against medical advise
TABLE 16
OUTCOME
No.of cases
Improved 90
Died 8
Deteriorated / Against Medical Advise 2
TABLE 17
Charecteristics of patients who died / deteriorated
No. of cases
Males 4
Females 6
TABLE 18
CAUSES
Causes No. of cases
DCLD/Hepatic Encephalopathy 2
Septic shock 1
Metabolic encephalopathy 2
AGE/ADD/ARF 1
Acute pyelonephritis 1
DM nephropathy/chronic 2
Brainstem stroke/chronic kidney 
disease/cerebral salt wasting syndrome 1

A report on mean initial and final sodium values are as follows:
Outcome Initial sodium Final sodium
Alive (N = 90)
Mean
Standard Deviation
Median
Maximum
Minimum
118.628
5.090
119.5
129
106
122.64
3.8198
124
135
114
Died / deteriorated  (N = 10)
Mean
Standard Deviation
Median
Maximum
Minimum
Total  N = 100
115.8
3.8529
116
120
108
121.2
3.084
120.5
126
116
Total: Mean 118.03 122.5
Standard Deviation 8.020 3.768
Median 119 123
Maximum 129 135
Minimum 106 114
The  mortality  did  not  correlate  with  severity  of  hyponatremia 
(p.value  0.125).   The  mortality  depended  on  the  underlying  illness  rather  than 
severity of hyponatremia.
PRIMARY DIAGNOSIS OF PATIENTS
S.No. Primary Diagnosis No. of patients
1. Bronchopneumonia/Acute bronchitis 6
2. DM Nephropathy/LVF 2
3. Brainstem stroke 3
4. GBS/AIDP 2
5. Diabetes Mellitus/Hyperglycemia 2
6. AGE/ADD 4
7. CKD 4
8. Sepsis, Acute Renal Failure other than CKD 4
9. DCLD/Hepatic Encephalopathy 3
10. Addison’s disease/Adrenal insufficiency 2
11. Cardiac failure 10
12. Metabolic encepholapathy 27
13. Pericardial effusion 1
14. Acute Infective cases 7
15. Acute Coronary Syndrome 1
16. Heat stroke 2
17. Chronic diarrhea 2
18. Fracture C6, C7 spine 1
S.No. Primary Diagnosis No. of patients
19. Hypoadrenalism 1
20. Seizure disorder 2
21. Chronic SDH 1
22. Post renal obstruction 1
23. TB Meningitis 3
24. Liver abscess 1
25. Hypopitutarism 3
26. Post-operative 2
27. Pulmonary TB 1
28. Miliary TB 2
29. Viral fever 4
30. Ca Esophagus  1
                                        N =  100 patients 105
(5 mixed causes)
DISCUSSION
In  the  present  study,  the  incidence  of  hyponatremia  was  (18.9%).   The 
incidence was 6.9% in the study done by Hochman103.  It was the most commonly 
ordered investigation among inpatients.   During the  period  of  the  present  study 
serum sodium was done in 8.2% of admitted patients.
The present study included patients with serum sodium less than 130 mEq/L. 
There were 57 males and 43 females with ratio of 1.32:1.  In general, in our hospital  
population,  there  were more males than females.   Hence,  this  slight  increase  in 
males was not very significant.   This ratio was more or less constant in all  age 
groups.  But in the age group above 70 years both genders were equal and in the age 
group of above 80 years comprised of only females.  No conclusion was made on 
this difference in incidence.   
In  the  present  study,  hyponatremia was  seen  more  commonly  in  patients 
above 45 years than in younger patients.  The ratio between numbers of patients 
above 45 years in comparison of  below 45 years 8.09:1.  Similar trend was also 
observed by Hochman103 Vurgese in their study has shown that elderly patients were 
more prone for hyponatremia.  The mean age in the present study was 62.46 years 
which was comparable to studies by Anderson9 where the mean age was 58 years 
and study done by Vuurgese103 where the mean age was 57.05 + 2SD.
The various factors responsible for hyponatremia in elderly are decreased 
glomerular filtration rate, impaired ability of kidney to conserve sodium, increased 
release of arginine vasopressin to a given osmotic stimulus, various drugs taken by 
them, decreasing appetite and concomitant illnesses.
Based on serum sodium concentration hyponatremia was classified as mild, 
moderate and severe with serum sodium 121 – 130mEq/L, 111 – 120mEq/L and 
less than or equal to 110mEq/L respectively.  There were 10(10%) patients with 
mild hyponatremia.  The degree of hyponatremia could more or less predict the 
symptoms  of  hyponatremia.   Some  patients  with  serum  sodium  greater  than 
120mEq/L had neurological symptoms like drowsiness.  But patients with serum 
sodium less than or equal to 110mEq/L showed severe neurological symptoms like 
seizures and unconsciousness. 
In  study  by  Hochman103 et  al,  there  were  39%  patients  with  mild 
hyponatremia and rest 61% had moderate to severe hyponatremia.  The presence or 
absence of symptoms and severity was more related to rapidity of fall  of serum 
sodium  rather  than  the  amount  of  fall.   The  elderly  patients  with  chronic 
hyponatremia can tolerate  lower levels  of  hyponatremia without  any symptoms. 
Hence, we conclude the more severe the hyponatremia and rapid fall  of sodium 
more severe the symptoms.
While analyzing history, 33% patients were only symptomatic and 67% were 
with neurological symptoms.
In  the  study  done  by  Hochman103,  there  were  43.4%  patients  with 
asymptomatic  ,  39.9% who had mild  symptoms  and 16.7% patients  has  severe 
neurological  symptoms  with  stupor  and  coma.   The  mean  serum  sodium  for 
asymptomatic  patients  was  120.26  and  symptomatic  was  116.88mEq/L.   The 
percentages of patients and mean serum sodium in the two groups are summarized 
in the following table, in comparison with study by Hochman.
Table 19
Hochman Present study
Symptoms % Patients Mean serum % Patients Mean Serum Na
Asymptomatic 43.4% 123 33% 120.26 + 3.27
Symptomatic 86.6% 120.8 67% 116.88 + 5.39
The  percentage  of  patients  in  various  groups  in  the  present  study  varies 
markedly with the above study.  The reason for this variation was probably due to 
the limited number of patients and selection criteria in the present study.  The mean 
serum sodium was slightly lower in all the groups in the present study as compared 
to the previous study except in the asymptomatic group.
The hydration status of the patients was diagnosed on the basis of clinical 
examination  and  was  divided  into  euvolumic,  hypovolumic  and  hypervolumic 
states.   In  the  present  study  62  patients  were  euvolumic,  19  patients  were 
hypovolumic and 19 patients were hypervolumic representing 62%, 19% and 19% 
of the patients respectively.
Table 20
Hyponatremia Hochman (%) Anderson (%) Present study (%)
Euvolumia 50 34 62
Hypovolumia 30.5 35 19
Hypervolumia 19.5 31 19
  This correlated with other studies where euvolumic hyponatremia was the 
commonest.  Further, SIADH was the most common diagnosis among this group of 
patients.  In study by Anderson9, 34% had euvolumia, 35% had hypovolumia and 
31% had hypervolumia.   In  study by Hochman103,  50% patients  had euvolumia, 
30.5% had hypovolumia and 19.5% had hypervolumia (Table 16).
Patients  with  euvolumia  were  more  symptomatic  and  had  more  severe 
symptoms  of  hyponatremia  compared to  the  other  groups.   The  average  serum 
sodium  was  117mEq/L.   75.8%  of  these  patients  were  symptomatic  with 
neurological symptoms.
In the study done by Vurgese104, the incidence of hyponatremia was 3.6% 
with the definition of hyponatremia as serum sodium levels  <130m mol/L.  The 
study population consisted of 66 patients with 56% males and 44% females.  The 
mean age was 57.05 + 2SD.  The commonest age group affected was 45 to 64 years 
(72.8%) and the least affected group was 12 to 25 years.  The common cause for  
hyponatremia was SIADH and pneumonia was the commonest cause of SIADH 
leading to hyponatremia.  One of the causes of SIADH was due to HIV infection. 
Renal  failure  and  congestive  cardiac  failure  was  the  next  frequent  causes  of 
hyponatremia.   A  majority  of  the  patients  (82%)  showed  mild  to  moderate 
hyponatremia (120 – 130 m mol/L).  Seasonal variation was noted in the study with 
59.1% patients presenting in the summer months.  The comparison of the present 
study with the study done by Vurgese104 is given in Table    .
Table 21
Vurgese Present Study
Incidence 3,6% 18.9%
Study population
56%
44%
57%
43%
Male
Female
Mean age 57.95 + 2SD 62.46 + 14.4
>45 years with Hyponatremia 722.8% 89%
Common causes SIADH SIADH
Other causes Renal Failure, CCF CCF, Renal Failaure
On the whole, SIADH was the most common cause of hyponatremia in the 
present study representing 28% of cases.  In other studies by Hochman103, SIADH 
represented 28.3% of cases, 34% in the study by Anderson9 and 34.8% in the study 
by Vurgese104.
In patients with euvolumic hyponatremia, 26 patients satisfied the criteria to 
diagnose SIADH.  They had low serum osmolality, high urine osmolality and high 
urine sodium.  However, in 2 patients in whom there were no other illness or in 
whom cause of SIADH was not obvious, we did other investigations like thyroid 
function tests and serum cortisol.  In patient in whom the cause of SIADH was 
obvious like stroke, we did not do thyroid function and serum cortisol.
The mean urine sodium was 66.29 + 37.04 mEq/L and urine osmolality was 
286.7  + 135.09 m Osm/L.  Urea and creatinine values were lower inpatients with 
SIADH.  Mean urea was 23 mg% and creatinine was 0.95 mg%.  Serum urea and 
creatinine are useful, as they generally are low and usually urea less than20 and 
creatinine less than 0.9 in most cases.  This might indicate an underlying SIADH.
Thyroid function tests and adrenal function
Thyroid  function  tests  and  random  serum  cortisol/ACTH  stimulation 
estimation test was done in a large number of patients.  There were a relatively large 
number  of  patients  with  hypothyroidism  (9%),  adrenal  insufficiency  (6%)  and 
panhypopituitarism (4%).  Although these endocrine abnormalities are known to 
cause hyponatremia, occurrence of these abnormalities in a relatively large susbset 
of  patients  needs  to  be  considered  and  endocrine  work-up  must  be  a  part  of 
investigations for severe hyponatremia.
16% of  patients had hypothyroidism and 10% had hypoadrenalism.  Patients 
with  hypothyroidism  and  hypoadrenalism  had  presentation  similar  to  SIADH. 
However, other features associated with these condition help to differentiate them 
from  SIADH.   Before  the  diagnosis  of  SIADH,  the  above  diseases  should  be 
excluded by appropriate investigations.
Patients with hypovolumic hyponatremia also had predominant moderated 
hyponatremia.  Among 7 patients with hypovolumic hyponatremia, one patient had 
cerebral salt wasting syndrome.
Majority  of  patients  with  hypervolumic  hyponatremia  had  mild 
hyponatremia.  The mean serum sodium was 116.7 mEq/L.
Treatment and monitoring
Monitoring of sodium was done on a 6 hourly to12 hourly basis in most of 
the patients with symptomatic and severe hyponatremia.  Fluid correction depended 
on the type, cause and present of symptoms.
The mean rate of correction was adequate and comparable with most of the 
international studies.  Normal saline alone, 3% saline, fluid restriction, + duration, 
dialysis,  steroids  alone  and in  combination  were  used to  treat  symptomatic  and 
severe hyponatremia.  One patient went into extra pontine myelinolysis but recovers 
with steroids and physiotherapy.  The mortality in this study (death/deterioration 
and against medical advice) is around 10% which is relatively low compared to 
other studies.  The mortality depended on severity of the underlying illness rather 
than the initial serum sodium, final serum sodium or the rate of correction.
The incidence of hyponatremia (18.9%) in our  study correlates well  with 
most of the other studies and estimates the high incidence of hyponatremia medical 
wards.   A  number  of  studies  have  evaluated  the  incidence  and  etiology  of 
hyponatremia  in  general,  but  there  are  very  few  relevant  studies  related  to 
hyponatremia  in  inpatients  in  medical  wards.   Delineating  the  cause  of 
hyponatremia  is  important  in  order  to  impart  specific  treatment  tailored  to  the 
etiology.
CONCLUSIONS
1. Symptomatic hyponatremia is common among the hospitalized patients.
2. Neurological symptoms are common in hyponatremia patients
3. SIADH and euvolumic  hyponatremia  formed  the  largest  subgroup  in  the 
study.
4. Drugs, especially diuretics, are a common cause of hyponatremia.
5. A relatively large number of patients had  endocrine abnormalities (thyroid, 
adrenal and pituitary).
6. The mortality  was about 10%.  It  was mainly due to underlying primary 
diseases.
7. Older age groups had more incidence of hyponatremia.
8. Symptoms of hyponatremia increased with severity of hyponatremia.
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PROFORMA
Incidence & etiology of hyponatremia
S.No                                       IP No.                                     Name:
Age                        Sex                     DOA                                      DOD           
Weight
Primary diagnosis:
SYMPTOMS
S.No. Symptoms Status Duration
1 Nausea Y N
2 Vomiting Y N
3 Headache Y N
4 Altered Mental Status Y N
5 Hiccups Y N
6 Seizures Y N
7 Others Y N
                            
If others, please specify                             
Diet Habits:
Fluid intake:
Decreased intake:
MEDICAL HISTORY
S.No. Co-morbid conditions Status Duration Specify
1 Diabetes Mellitus Y N
2 Hypertension Y N
3 Cardiovascular Y N
4 Renal Problems Y N
5 Endocrine Y N
6 Respiratory Y N
7 Neurological Y N
8 Gasterointestinal Y N
9 Others Y N
If others, please specify
CURRENT MEDICATIONS
S.No. Drug Name Duration Dosage/day Causes 
Hyponatremia
1 Y N
2
3
4
5
6
CLINICAL FINDINGS
Pulse Rate / min. Blood Pressure            mmHg
Volume status at the time of admission:  Hypovolemic / Hypervolemic / Euvolemic
Oedema: Y / N        Ascites / Pedaledema 
Dehydration: Y / N
BIOCHEMICAL PARAMETERS (At the time of admission)
Serum sodium level: Urine spot sodium:
Serum osmolality: Urine osmolality:
Na               Urea        Glucose
Random Serum Cortisol:    Done / Not done Random serum cortisol level:
ACTH stimulation test:
TFT:    Done / Not done TSH:                  Free T4:
Calculated sodium deficit: Diuretics    Y / N
Infusion Plan: Fluid restriction Y / N
Specific drugs
Outcome:  Asymptomatic / Symptomatically better / Same status 
Discharged / Death / AMA / Transfer
Hyponatremia Cause 
Possible secondary cause
Formula
Calculated serum osmolality: 2  x  Na  +  Glu / 18   +   Urea/6
ABBREVIATIONS
• ADH : Antidiuretic hormone
• AIDS : Acquired Immuno Deficiency Syndrome
• ANOVA : Analysis of variance
• ARC : Aids-related Complex
• ATPase : Adenosine Triphosphatase
• AVP : Arginine vasopressin
• C : Centigrade
• cAMP : Cyclic adenosine monophosphate
• Cl : Chloride
• COPD : Chronic Obstructive Pulmonary Disease
• CO3 : Carbonate
• Dl : Deciliter
• FE : Fractional Excretion
• G : Gram
• GFR : Glomerular Filtration Rate
• H+ : Hydrogen ion
• H2O2 : Hydrogen peroxide
• H2O : Water
• HCo3 : Bicarbonate
• HIV : Human Immunodeficiency virus
• hrs : Hours
• IHD : Ischemic Heart Disease
• ISE : Ion Selective Electrodes
• K+ : Potassium
• Kg : Kilogram
• L : Litre
• MDMA : 3,4 Methylenedioxymethamphetamine
• mEq : Milliequivalents
• mg : Milligram
• Mmol : Millimoles
• m Osm : Milliosmoles
• N2 : Nitrogen
• Na+ : Sodium
• NAD+ : Nucleotide Adenine Dinucleotide
• NAD(P) : Nucleotide Adenine Dinucleotide Phosphate
• ng : Nanogram
• NH4+ : Ammonium
• NSAID’s : Non Steroidal Anti-inflammatory drugs
• O2 : Oxygen
• Pg : Pictogram
• PTB : Pulmonary Tuberculosis
• SIADH : Syndrome of Inappropriate Antidiuretic 
Hormone
• SD : Standard Deviation
• % : Percentage
•
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1 Suresh 60 M 17/1/08 Yes No Yes
BRONCHOPNEUMONIA/
?ca bronchus No Yes No No Yes No Yes No No No No No No euvolemic 119 125 74 612 249 Normal Normal Normal saline symptomatic SIADH multifactorial improved No
2 Vivekananda 53 M 10/1/2008 Yes No No DM nephropathy/LVF No Yes No Yes Yes Yes No Yes No No No No Yes hypervolemic 121 125 16 130 268 Normal Normal
fluid rest/
diuretics symptomatic volume overload single improved No
3 Mani loganathan 60 M 13/1/08 Yes Yes No brainstem stroke/CKD Quadriparesis Yes Yes Yes Yes Yes No Yes No No aspiration pneumonia No Yes hyp ovolemic 119 126 120 No 278 Normal Not done 3%saline symptomatic
cerbral salt wasting 
syndrome
CKD multifactorial death No
4 Dhanap al 70 M 24/1/08 Yes Yes No GBS Quadriparesis No No Yes No No Yes No No No No No No euvolemic 124 125 80 180 252 Normal Normal Normal saline asymptomatic SIADH single improved No
5 Ramanathan 66 M 25/1/08 Yes Yes Yes DKA/DM
Headache 
nausea Yes Yes Yes No No No No No Yes acidosis No No hyp ovolemic 120 124 100 No 271 Normal Not done Normal saline symptomatic
dehy dration
hyp ergly cemia multifactorial improved No
6 sury anaray ana 51 F 4/2/2008 Yes Yes No AGE/ADD vomiting Yes No No No No No No No diarrhea dehydration No No hyp ovolemic 125 128 8 No 264 Not done Not done Normal saline symptomatic diarrhea single improved No
7 thanthoni 45 M 6/2/2008 Yes No No hy perglycemia No No No Yes No No No No No No No No No euvolemic 121 123 No 110 322 No Not done
insulin
Normal saline asymptomatic pseudohy ponatremia single improved No
8 purushoathaman 65 M 8/2/2008 Yes Yes No CKD Hiccoughs Yes No Yes Yes No Yes Yes No Yes pleural effusion No Yes hypervolemic 118 121 10 No 275 Normal Not done
fluid rest/
diuretics symptomatic volume overload single deteriorated No
9 tamay anthi 62 F 15/2/08 Yes No Yes
sepsis, uti
renal failure, AIDP,
Flaccid 
quadriparesis No No Yes Yes No No Yes No No pyoderma No Yes euvolemic 116 120 10 80 288 Normal Normal dialysis asymptomatic renal failure single improved No
10 mohamed shafi 55 F 22/2/08 Yes No No DCLD/hepatic encephalop athy Drowsiness Yes No Yes Yes No No Yes No ascites No No Yes hypervolemic 118 122 12 100 289 No Not done
fluid rest/
diuretics symptomatic ascites,renal failure multifactorial death No
11 parvati 60 F 22/2/08 Yes Yes No DM nephropathy/CKD No No No Yes Yes No No Yes No Yes ascites Yes Yes hypervolemic 114 120 14 156 246 No Not done
fluid rest/
diuretics asymptomatic
renal failure 
volume overload multifactorial deteriorated No
12 rajesh 19 M 24/2/08 Yes No Yes
Disseminated TB,
Addisons Disease No No No No No No Yes No Yes vomiting shock Yes No euvolemic 121 122 20 150 262 Normal
done/primary 
addisons disease sterioids asymptomatic addisons disease single improved Yes
13 somu 41 M 2/3/2008 Yes No Yes cardiac failure Yes Yes No Yes Yes Yes No Yes No No No Yes Yes hypervolemic 108 116 109 100 260 Normal Normal diuretics symptomatic volume overload single improved No
14 chakrpani 68 M 4/3/2008 Yes Yes Yes metabolic encep halopathy Yes Yes No Yes Yes Yes Yes Yes No No No Yes No euvolemic 112 116 68 321 280 hypothyroid Normal diuretics symptomatic hyp othyroidism multifactorial improved Yes
15 sylvia 71 F 16/3/08 Yes Yes Yes metabolic encep halopathy Yes Yes No No Yes Yes Yes No No No dyslipidemia No Yes euvolemic 106 115 67 336 296 Normal Normal 3%saline symptomatic diuretic induced multifactorial improved No
16 anandraj 67 M 18/3/08 Yes Yes Yes metabolic encep halopathy Yes Yes No No No No Yes No No No recent spine surgery Yes No euvolemic 111 117 40 170 286 Normal
done/
adrenal 
insufficiency steriods symptomatic adrenal insufficeincy single improved Yes
17 alamelu 85 F 19/3/08 Yes Yes No AGE/ADD No No No Yes Yes No No No No No osteoporosis Yes No euvolemic 121 125 61 242 270 Normal Normal 3%saline asymptomatic SIADH multifactorial improved No
18 venkateshwara rao 70 M 20/3/08 Yes Yes Yes metabolic encep halopathy Yes Yes No Yes No No No No No No cervical spondylosis Yes Yes euvolemic 115 120 21 208 268 Normal Normal diuretics symptomatic diuretic induced single improved No
19 sebastian 67 M 5/4/2008 Yes Yes No metabolic encep halopathy Yes Yes No Yes Yes No No No No No No Yes No euvolemic 113 120 45 205 287 Normal Normal 3%saline symptomatic SIADH single improved No
20 rangabashy am 71 M 6/4/2008 Yes Yes No metabolic encep halopathy Yes Yes No No No No No No No No No Yes No euvolemic 117 123 90 412 260 Normal Normal 3%saline symptomatic SIADH single improved No
21 saraswati 68 F 10/4/2008 Yes Yes Yes pericardial effusion No No No No No Yes No No No No anemia Yes No hypervolemic 119 123 65 262 280 Normal Normal
3%saline+
diuretics asymptomatic dilutional hyponatremia single improved No
22 valli 60 F 12/4/2008 Yes Yes No acute infective cause Yes Yes No No No No Yes No No No recent uti Yes No euvolemic 123 126 28 185 268 Normal Not done Normal saline symptomatic advised pituatry work up single improved Yes
23 kulusum beevi 45 F 19/4/08 Yes Yes Yes acute coronary syndrome No No No No Yes Yes No No No No dyslipidemia No No euvolemic 121 123 29 190 270 hypothyroid Normal NS asymptomatic hyp othyroidism multifactorial improved Yes
24 chandbasha 56 M 23/4/08 Yes Yes Yes heat stroke Yes Yes No Yes No No No No No No No No No hyp ovolemic 122 125 150 503 272 Normal Not done NS symptomatic
dehy dration,
?adrenal insufficiency multifactorial improved No
25 rubaroy 68 F 1/5/2008 Yes Yes No chronic diarrhea No No No No Yes No No No No No No Yes No hyp ovolemic 118 123 150 503 280 hypothyroid Normal NS asymptomatic dehy dration,hyp othyroid multifactorial improved Yes
26 jayalaksmi 85 F 3/5/2008 Yes Yes Yes cardiac failure No No No No Yes No No No No No Yes Yes Yes hypervolemic 120 126  -  - 270 Normal Normal diuretics asymptomatic volume overload multifactorial improved No
27 radhakrishnan 82 M 18/5/08 Yes Yes Yes heat stroke Yes Yes No No Yes No No No No No No No No hyp ovolemic 117 121 62 440 280 Normal Normal NS symptomatic dehy dration single improved No
28 palaniappan 60 M 20/5/08 Yes Yes Yes metabolic encep halopathy Yes Yes Yes No Yes No No No No No No Yes Yes euvolemic 106 115 11 360.9 290 Normal Normal 3% saline symptomatic diuretic induced single improved No
29 krishnamachari 72 M 28/5/08 No Yes Yes acute infective cause Yes Yes No Yes Yes Yes Yes Yes No No No No No euvolemic 120 125 106 486 278 hypothyroid Not done NS symptomatic hyp othyroidism multifactorial improved Yes
30 sundarajan 72 M 3/6/2008 Yes Yes No cardiac failure No No No No Yes Yes No Yes No No No No No hypervolemic 120 124 108 490 260 Normal Not done diuretics asymptomatic volume overload multifactorial improved No
31 chellamal 60 F 4/6/2008 Yes Yes Yes fracture C6 C7 Yes Yes No No No No Yes No No No No Yes No hyp ovolemic 106 115 54 220 280 Normal Not done NS symptomatic hyp ovolemia single improved No
32 elizabeth 75 F 9/6/2008 Yes Yes Yes hy poadrenalism Yes Yes No No No No No No No No No Yes No euvolemic 116 121 96 345 280 Normal done/low NS symptomatic adrenal insufficeincy single improved Yes
33 muralidharan 49 M 10/6/2008 Yes Yes No metabolic encep halopathy Yes No Yes Yes Yes No No No No No No No Yes euvolemic 113 119 54 401 290 Normal Normal 3% saline symptomatic diuretic induced single death No
34 govindammal 62 F 19/6/08 Yes Yes Yes metabolic encep halopathy Yes Yes No Yes Yes No No No Yes No No No Yes euvolemic 106 117 32 198 262 Normal Normal NS, 3% saline symptomatic diuretic induced multifactorial improved No
35 radhabai 51 F 28/6/08 Yes Yes Yes cardiac failure No No No No No Yes No No No No No No Yes hypervolemic 126 127 68 180 260 Not done Not done diuretics asymptomatic volume overload single improved No
36 senthaamarai 65 F 23/7/08 Yes Yes Yes stroke Yes Yes No Yes Yes No No No No No No No Yes hyp ovolemic 114 120 35 280 275 Normal Normal NS symptomatic diuretic induced single improved No
37 ramanathan 88 M 24/7/08 Yes Yes No metabolic encep halopathy Yes Yes No Yes Yes Yes No No No No No No Yes euvolemic 124 126 106 340 280 Normal Normal NS symptomatic diuretic induced single improved No
38 soundarajan 63 M 25/7/08 Yes Yes No acute calculus cholecystitis Yes No No Yes Yes Yes No No No Yes Yes No No hyp ovolemic 122 125 35 265 263 Normal Normal NS asymptomatic hyp ovolemia multifactorial improved No
39 kasturi 70 F 28/7/08 Yes Yes Yes metabolic encep halopathy Yes Yes No No No No No No No No No Yes No euvolemic 124 126 94 380 280 Normal Normal NS symptomatic SIADH single improved No
40 geetha 52 F 28/7/08 Yes Yes No seizure disorder Yes No No Yes No Yes No No No No No Yes No euvolemic 117 122 120 585 276 Normal Normal NS symptomatic SIADH single improved No
41 krishnamurthy 81 M 4/8/2008 Yes Yes No chronic SDH Yes Yes Yes No No No Yes No No No No Yes No euvolemic 121 123 64 317 260 Normal Normal NS symptomatic SIADH multifactorial improved No
42 yogam 78 F 6/8/2008 Yes Yes No cardiac failure Yes Yes No Yes Yes Yes No No Yes No No No No euvolemic 118 124 30 210 278 hypothyroid Not done 3% saline symptomatic
dilutional hyponatremia 
hyp othyroidism multifactorial improved Yes
43 narayanasamy 81 M 7/8/2008 Yes Yes No post renal obstruction No No No Yes Yes No No Yes No No Yes Yes No euvolemic 120 124 66 172 290 Normal Not done NS asymptomatic post obstructive diuresis multifactorial improved No
44 narayannair 75 M 10/8/2008 Yes Yes No metabolic encep halopathy Yes Yes Yes Yes Yes Yes No No No No No No Yes euvolemic 123 126 156 434 276 Normal Not done NS symptomatic diuretic induced single improved No
45 ramasamy 55 M 19/8/08 Yes Yes No renal failure No No No Yes No Yes No Yes No No No No No hypervolemic 118 121 46 180 260 Not done Not done diuretics asymptomatic renal failure single improved No
46 pushpa 46 F 20/8/08 Yes Yes Yes tb meningitis No No No Yes Yes No No No No Yes No No No euvolemic 122 124 112 320 271 Normal Not done NS, 3% saline asymptomatic SIADH multifactorial improved No
47 chandramohan 54 M 7/9/2009 Yes Yes Yes liver abscess No No No Yes Yes Yes No No No No No No No euvolemic 119 125 52 310 280 Normal Not done NS asymptomatic unclear unclear improved No
48 padmavathy 57 F 8/9/2009 Yes Yes No hy pop ituitarism Yes Yes No No No Yes No No No No No No No hypervolemic 122 124 111 504 268 hypothyroid done/low NS symptomatic panhypopituitarism multifactorial improved Yes
49 govindammal 83 F 11/9/2009 Yes Yes No chronic diarrhea No No No Yes No No No Yes No No No Yes No hyp ovolemic 118 123 45 292 278 Normal Normal NS, 3% saline asymptomatic SIADH multifactorial improved No
50 prema 64 F 17/9/09 Yes Yes No acute pyelonephrit is Yes No No Yes Yes No No Yes No No No No No hypervolemic 120 125 26 256 280 Normal Not done NS, 3% saline symptomatic renal failure single death No
51 george 51 M 19/9/09 Yes Yes No hy pop ituitarism Yes No No Yes Yes No No No No Yes No No No euvolemic 120 124 94 310 270 hypothyroid done/low 3% saline symptomatic panhypopituitarism multifactorial improved Yes
52 visalakshi 81 F 23/9/09 Yes Yes Yes postoperative No No No No No Yes Yes No No No No No No euvolemic 124 127 36 146 256 Normal Normal NS asymptomatic unclear unclear improved No
53 ramamurthy 60 M 9/10/2009 No Yes No tb meningitis Yes Yes No Yes Yes No No No No No No No No euvolemic 120 124 100 580 260 Normal Normal 3% saline symptomatic SIADH multifactorial improved No
54 kandasamy 47 M 11/10/2009 No Yes Yes GBS Yes Yes No No No No No No No No No No No euvolemic 116 121 130 644 262 Normal Normal 3% saline symptomatic pseudohy ponatremia single improved No
55 sumathi 51 F 14/10/09 Yes Yes Yes cardiac failure No No No Yes No Yes No No Yes No No No Yes hypervolemic 122 125 85 225 260 Normal Not done diuretics asymptomatic volume overload single improved No
56 anthonysamy 79 M 15/10/09 Yes Yes No metabolic encep halopathy Yes Yes No Yes Yes No No No No No No No No euvolemic 121 126 100 97 264 hypothyroid Normal 3% saline symptomatic hyp othyroidism single improved Yes
57 citibabu 53 M 18/10/09 No Yes Yes tb meningitis Yes Yes Yes No No Yes No No No No No No No euvolemic 116 120 85 420 265 Normal Not done 3% saline symptomatic SIADH multifactorial improved No
58 begamjan 67 F 28/10/09 Yes Yes No septic arthritis Yes No No No No No No No No No No No No euvolemic 119 121 65 330 281 Normal Normal 3% saline symptomatic unclear ? SIADH multifactorial improved No
59 parvathi 54 F 3/11/2009 Yes Yes No metabolic encep halopathy No No No Yes Yes No No No No No No Yes Yes euvolemic 114 120 55 173 270 Normal Not done NS asymptomatic diuretic induced multifactorial improved No
60 venkatesan 60 M 4/11/2009 Yes Yes Yes pulmonary tb Yes No No No No No No No No No No No No euvolemic 123 125 10 112 270 Normal Normal 3% saline symptomatic SIADH single improved No
61 prem malik 39 M 5/11/2009 Yes Yes No acute infective cause Yes Yes No No Yes No Yes No No No p sychiatric Yes No euvolemic 122 124 48 517 264 Normal Normal 3% saline symptomatic SIADH single improved No
62 srinivasan 49 M 19/11/09 Yes Yes No miliary tuberculosis Yes No No No Yes No No No No No nephrolithiasis Yes No euvolemic 120 125 63 307 275 Normal Normal 3% saline symptomatic SIADH single improved No
63 mariyam biwi 58 F 20/11/09 Yes Yes No AGE/ADD?ARF Yes Yes Yes No No No No Yes No No No No No hyp ovolemic 114 120 61 277 271 Not done Not done NS, 3% saline symptomatic hyp ovolemia multifactorial death No
64 sivalingam 72 M 22/11/09 Yes Yes No metabolic encep halopathy Yes Yes No No Yes No No No No No No No No euvolemic 107 114 63 224 258 Normal Not done 3% saline symptomatic SIADH multifactorial improved No
65 manivannan 74 M 4/12/2009 Yes Yes No metabolic encep halopathy Yes Yes No No Yes No No No No No No No No euvolemic 112 118 83 210 270 Normal Not done 3% saline symptomatic SIADH multifactorial improved No
66 krishnamurthy 80 M 5/12/2009 Yes Yes Yes metabolic encep halopathy Yes Yes No No Yes No No No No No No No No euvolemic 125 127 57 210 282 hypothyroid Not done NS symptomatic hyp othyroidism single improved Yes
67 seetha 46 F 7/12/2009 Yes Yes No hy pop ituitarism Yes No No Yes No No No No No No No No No euvolemic 114 119 90 252 260 hypothyroid done/low 3% saline symptomatic panhypopituitarism single improved Yes
68 durai 27 M 9/12/2009 No Yes Yes young stroke Yes Yes Yes No No No No No No No No No No euvolemic 119 124 100 300 275 Normal done/low NS symptomatic adrenal insufficeincy single improved Yes
69 ramamurthy 71 M 10/12/2009 Yes Yes No staphylococcus sepsis Yes No No No No No No No No No No No No euvolemic 116 120 117 520 270 Normal Normal 3% saline asymptomatic SIADH unclear improved No
70 prema 52 F 28/12/09 No Yes No metabolic encep halopathy Yes Yes No Yes Yes Yes No Yes No No No Yes Yes hypervolemic 110 116  -              - 276 hypothyroid Normal 3% saline symptomatic hyp othyroidism multifactorial improved Yes
71 sathyanarayana 57 M 29/12/09 Yes Yes No viral fever Yes No No Yes Yes No No No No No No No No hyp ovolemic 129 135 119 425 270 Not done Not done NS asymptomatic hyp ovolemia single improved No
72 yogalakshmi 78 F 3/1/2010 Yes Yes No metabolic encep halopathy Yes Yes No Yes No Yes No No No No osteoporosis Yes Yes euvolemic 114 119 30 118 272 hypothyroid Normal NS symptomatic hyp othyroidism multifactorial death Yes
73 murugesan 61 M 4/1/2010 Yes Yes No rickettsial fever Yes No No No No No Yes Yes No Yes purpuric rashes No No hyp ovolemic 120 125 38 130 268 Not done Not done NS asymptomatic hyp ovolemia single improved No
74 alamelu 72 F 5/1/2010 Yes Yes No metabolic encep halopathy Yes No No Yes Yes No No No No No No Yes Yes euvolemic 118 123 123 352 260 hypothyroid Not done NS asymptomatic diuretic induced multifactorial improved Yes
75 subbammal 75 F 18/1/10 Yes Yes No pneumonia No No No Yes No No Yes No No No No Yes Yes hyp ovolemic 121 126 53 304 280 Normal Normal NS asymptomatic SIADH single improved No
76 srinivasan 78 M 22/1/10 Yes Yes Yes viral fever Yes Yes No No Yes Yes No No No No No No No euvolemic 117 121 38 215 268 Not done Not done NS symptomatic hyp ovolemia single improved No
77 venkatesan 78 M 28/1/10 Yes Yes No ca oesophagus Yes Yes No Yes No Yes No No No No No No No euvolemic 118 124 28 178 280 Normal Normal NS symptomatic SIADH single improved No
78 lakshmi 82 F 28/1/10 Yes Yes No metabolic encep halopathy Yes Yes No No Yes No Yes No No No p sychiatric No No euvolemic 116 119 29 230 276 Normal Normal NS symptomatic SIADH single improved No
79 sushma 37 F 4/2/2010 Yes Yes No pneumonia Yes Yes Yes Yes No No No No No No No No No euvolemic 124 126 10 114 270 Not done Not done NS symptomatic hyp ovolemia single improved No
80 seetha 76 F 5/2/2010 No Yes No metabolic encep halopathy Yes Yes No Yes Yes No No No Yes No No Yes No euvolemic 122 126 80 336 270 Normal Not done 3% saline symptomatic SIADH single improved No
81 gopal 58 M 6/2/2010 Yes Yes No viral fever Yes Yes No No No No Yes No No No No Yes No hyp ovolemic 125 128 12 117 282 Not done Not done NS symptomatic hyp ovolemia single improved No
82 jamuna 68 F 7/2/2010 Yes Yes No cardiac failure No No No No Yes Yes No No No No No No No hypervolemic 119 124 93 273 260 Not done Not done diuretics asymptomatic volume overload single improved No
83 vasantha 68 F 17/2/10 Yes Yes Yes cardiac failure No No No No Yes Yes No No No No No Yes No hypervolemic 122 126  -  - 270 Not done Not done 3% saline asymptomatic volume overload single improved No
84 soundarajan 72 M 26/2/10 Yes Yes No acute infective cause Yes Yes No Yes No Yes No No No No No Yes No euvolemic 116 119 92 443 260 hypothyroid Not done 3% saline symptomatic hyp othyroidism single improved Yes
85 samp ath 74 M 28/2/10 Yes Yes No viral fever Yes Yes No Yes Yes No No No No No No Yes Yes euvolemic 122 125 95 205 268 Not done Not done NS symptomatic diuretic induced single improved No
86 subashini 43 F 3/3/2010 Yes Yes Yes cardiac failure No No No Yes Yes Yes No No No No No Yes Yes hypervolemic 116 120 46 271 264 Not done Not done fluid restriction asymptomatic volume overload single improved No
87 ganesh rao 74 M 4/3/2010 Yes Yes No metabolic encep halopathy No Yes Yes No Yes No No No No No No No No euvolemic 117 120 49 380 270 Normal Normal 3% saline symptomatic SIADH unclear improved No
88 ramdoss 65 M 9/3/2010 Yes Yes No seizure disorder Yes No Yes Yes Yes Yes No No No No BPH Yes No hyp ovolemic 108 118 67 361 270 Not done Not done NS symptomatic diuretic induced single improved No
89 kamalam 70 F 18/3/10 Yes Yes Yes septic shock Yes Yes No Yes Yes No No No Yes No Yes No Yes hyp ovolemic 108 116 117 436 268 Not done done/low NS symptomatic adrenal insufficeincy multifactorial death Yes
90 subbiah 61 M 20/3/10 Yes Yes No hy pop ituitarism Yes Yes No No No No No No Yes No No No No euvolemic 122 126  -  - 268 hypothyroid done/low 3% saline symptomatic panhypopituitarism single improved Yes
91 ramasamy 50 M 21/3/10 Yes Yes No metabolic encep halopathy Yes Yes Yes Yes Yes No No No No No p sychiatric Yes Yes euvolemic 110 116 46 177 268 hypothyroid Not done 3% saline symptomatic hyp othyroidism single improved Yes
92 kupp ammal 42 F 11/4/2010 Yes Yes Yes cardiac failure Yes No No Yes No No No No No Yes No No No hypervolemic 121 125 159 460 267 Not done Not done diuretics asymptomatic volume overload single improved No
93 Pattamal 83 F 12/4/2010 Yes Yes No metabolic encep halopathy Yes No No Yes Yes No No No No No mo Yes No euvolemic 125 128 75 245 260 Normal Normal NS asymptomatic SIADH multifactorial improved No
94 kabir 77 M 13/4/10 Yes Yes No acute bronchitis Yes Yes No Yes Yes Yes No No No Yes ca prostate Yes No hyp ovolemic 120 125 83 280 262 Normal Not done NS symptomatic hyp ovolemia single improved No
95 anthonysamy 50 M 19/4/10 Yes Yes No DCLD/hepatic encephalop athy No No No Yes Yes No No No No No No Yes No hypervolemic 120 124 40 230 256 Not done Not done diuretics asymptomatic liver failure, renal failure multifactorial death No
96 sriram 18 M 22/4/10 Yes Yes No AGE Yes No No No No No No No No Yes No No No hyp ovolemic 118 122 86 220 264 Not done Not done NS asymptomatic hyp ovolemia single improved No
97 kala 73 F 3/5/2010 Yes Yes No metabolic encep halopathy Yes Yes No No Yes No No No No No No Yes Yes euvolemic 111 115 41 478 276 Not done Not done 3% saline symptomatic diuretic induced single improved No
98 kannapp an 67 M 4/5/2010 Yes Yes No metabolic encep halopathy Yes No No No Yes No No No No No BPH Yes Yes euvolemic 124 128 83 250 272 Not done Not done NS asymptomatic diuretic induced single improved No
99 shankaran 55 M 14/5/10 Yes Yes No acute infective cause No Yes No Yes No No Yes No No No No No No euvolemic 112 117 20 85 276 Normal done/low 3% saline symptomatic adrenal insufficeincy single improved Yes
100 kamal 30 M 13/6/10 No Yes No RTA, necrotising pneumonia Yes Yes Yes No No No No Yes No No No No No euvolemic 120 123 28 90 280 Normal Normal 3% saline symptomatic SIADH multifactorial improved No
